Regulatory Management of Substance Use in High-Risk Nurse Populations

被引:3
|
作者
Malliarakis, Kate Driscoll [1 ]
Smith, Valerie [2 ]
Darbro, Nancy [3 ]
机构
[1] George Washington Univ, Sch Nursing Washington, MSN Nursing Leadership & Management Program, Washington, DC 20052 USA
[2] Arizona Board Nursing BON, Phoenix, AZ USA
[3] New Mexico BON Div Program, Phoenix, AZ USA
关键词
D O I
10.1016/S2155-8256(15)30253-2
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The regulatory management of nurses with substance use disorders has continued to evolve based on emerging evidence. In 2008, the National Council of State Boards of Nursing convened an interdisciplinary committee to review current literature and evidence and provide evidence-based recommendations on the regulatory management of nurses with substance use disorders. The committee also identified several populations at high risk for substance abuse or relapse. These populations include nurses being treated with prescription drugs, such as analgesics, anxiolytics, antidepressants, and potentially mindaltering drugs for such conditions as chronic pain, depression, anxiety, chemical dependence, and addiction. This article addresses the regulatory management of practicing nurses with this dual challenge of having a substance use disorder and a medical need to use drugs that can trigger relapse.
引用
收藏
页码:32 / 37
页数:6
相关论文
共 50 条
  • [21] Risk factors and high-risk populations
    Snider, GL
    REVUE DES MALADIES RESPIRATOIRES, 1998, 15 : S5 - S9
  • [22] Developing a protocol for substance use screening and referral to treatment for FQHC patients with high-risk substance use
    Seth, I.
    Sirisoma, A.
    Rico, M. W.
    Sumstine, S.
    Cazares, L.
    Gelberg, L.
    Swendeman, D.
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 47 : 247 - 247
  • [23] Use of the child development inventory to screen high-risk populations
    Montgomery, ML
    Saylor, CF
    Bell, NL
    Macias, MM
    Charles, CM
    Katikaneni, LDP
    CLINICAL PEDIATRICS, 1999, 38 (09) : 535 - 539
  • [24] Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations
    Bergman, Scott J.
    Speil, Cristian
    Short, Michael
    Koirala, Janak
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2007, 21 (03) : 821 - +
  • [25] Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth
    Krausz, Michael
    Westenberg, Jean N.
    Tsang, Vivian
    Suen, Janet
    Ignaszewski, Martha J.
    Mathew, Nickie
    Azar, Pouya
    Cabanis, Maurice
    Elsner, Julie
    Vogel, Marc
    Spijkerman, Renske
    Orsolini, Laura
    Vo, Dzung
    Moore, Eva
    Moe, Jessica
    Strasser, Johannes
    Koeck, Patrick
    Marian, Calin
    Duersteler, Kenneth M.
    Backmund, Markus
    Roehrig, Jeanette
    Post, Marianne
    Haltmayer, Hans
    Wladika, Wolfgang
    Trabi, Thomas
    Muller, Christian
    Rechberger, Gerhard
    Teesson, Maree
    Farrell, Michael
    Christie, Grant
    Merry, Sally
    Mamdouh, Mostafa
    Alinsky, Rachel
    Levy, Sharon
    Fishman, Marc
    Rosenthal, Richard
    Jang, Kerry
    Choi, Fiona
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [26] Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users
    Chen, Xiaoxue
    Ma, Qinli
    Barron, John
    DeVries, Andrea
    Horn, Jennifer
    Agiro, Abiy
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (03): : 392 - 401
  • [27] THE IDENTIFICATION OF HIGH-RISK POPULATIONS
    LIPKIN, M
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1984, 19 : 91 - 97
  • [28] High-Risk Populations Introduction
    Howard, George
    Sacco, Ralph L.
    STROKE, 2009, 40 (03) : S71 - S72
  • [29] NUTRITION IN HIGH-RISK POPULATIONS
    LIDDLE, VR
    ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 882 - 882
  • [30] Targeting high-risk populations
    Jönsson, B
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 : S13 - S16